IBM Offloads Watson Health Division as Tech Valuations Cool
IBM sells its Watson Health unit to Francisco Partners, marking a major shift for the once-heralded AI project. The move comes amid broader market turbulence and cooling tech valuations.
IBM sells its Watson Health unit to private equity firm Francisco Partners, marking a significant retreat from the healthcare artificial intelligence market. The deal highlights the immense difficulty of applying cutting-edge AI to the highly regulated and complex medical industry, a challenge that has plagued the Watson division since its ambitious inception.
This major corporate divestment occurs during a turbulent week for the technology sector, as demonstrated by Netflix's plummeting stock price after disappointing earnings. These financial shocks underscore a broader market shift away from the pandemic-era tech boom, proving that the era of inflated super-rich tech valuations is officially coming to an end.
Other major tech players are also experiencing significant strategic shifts, with Microsoft facing unexpected union complications in its pending Activision Blizzard acquisition and Meta choosing to keep its internal Slack competitor in-house despite lucrative spin-off offers. Meanwhile, the startup world continues to see targeted investments, with European corporate spend startup Moss raising $86 million and Cana Technology unveiling a futuristic molecular beverage printer.